SCHEMBL12608342

SCHEMBL12608342

C=CCNC(=O)C(=O)[C@@H]1CCCCCCCOCC(NC(=O)N[C@H](CN2C(=O)C(=C)CCC(C)C2=O)C(C)(C)C)C(=O)N2C[C@H]3[C@@H]([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8038618 1.00 — —
SCHEMBL8053405 0.94 — —
SCHEMBL8050568 0.90 — —
SCHEMBL12606772 0.89 CPB2 (0.30) —
SCHEMBL13685112 0.89 CPB2 (0.30) —
SCHEMBL12607198 0.88 — —
SCHEMBL8045437 0.86 PSMB9 (0.34) —
SCHEMBL8046979 0.86 — —
SCHEMBL8290534 0.85 — —
SCHEMBL12606660 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback